Verified Nov 2026
Other
·

Cambridge, England
·
Since 1999
AstraZeneca is a global biopharmaceutical company headquartered in Cambridge, England, founded in 1999 through a merger of Astra AB and Zeneca Group PLC. With approximately 90,000 employees and over $10 billion in annual revenue, it operates in more than 130 countries and serves oncology, cardiovascular, respiratory, immunology, vaccines, and rare disease sectors. The company announced a $15 billion investment plan in China through 2030 to develop next-generation medicines.
Astra Zeneca at a glance
Revenue
$10B+
Est. band
Employees
50,000-100,000
Founded
1999
Headquarters
Cambridge, England
Certifications
ISO 14001 · ISO 50001
Import activity
10
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
10
Named foreign suppliers
1
Top origins
Mexico

Shared foreign counterparties do not establish that these companies buy from Astra Zeneca.
What this tells a buyer
The company reported 10 shipments originating from Mexico according to customs records.
AstraZeneca maintains ISO 14001 and ISO 50001 certifications and operates a pipeline of over 190 drug development projects across multiple therapeutic areas.
The company serves more than 100 million patients annually and operates manufacturing and research facilities in Virginia and Shijiazhuang, China.
Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026
STABILITY SIGNALS
Established & active
27 years in operation (founded 1999).
10 US import shipments on record.
Holds ISO 14001, ISO 50001 certification(s) per public sources.
Overview
AstraZeneca is a global biopharmaceutical company headquartered in Cambridge, England, founded in 1999 through a merger of Astra AB and Zeneca Group PLC. With approximately 90,000 employees and over $10 billion in annual revenue, it operates in more than 130 countries and serves oncology, cardiovascular, respiratory, immunology, vaccines, and rare disease sectors. The company announced a $15 billion investment plan in China through 2030 to develop next-generation medicines.
At a glance
Attribute | Detail |
|---|---|
Founded | 1999 |
Headquarters | Cambridge, England |
Employees | 50,000-100,000 |
Revenue | $10B+ (estimated) |
Certifications | ISO 14001 · ISO 50001 |
What Astra Zeneca makes
AstraZeneca maintains ISO 14001 and ISO 50001 certifications and operates a pipeline of over 190 drug development projects across multiple therapeutic areas.
Certifications
Astra Zeneca is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 14001 — weareinteb.co.uk
ISO 50001 — weareinteb.co.uk
Trade and customs footprint
The company reported 10 shipments originating from Mexico according to customs records. US customs bill-of-lading records list 10 inbound shipments across 1 foreign suppliers, with top origins including Mexico.
Latest developments
2026-11-10 — AstraZeneca to Adopt RISE with SAP and Business AI | SAP News Center (sap.com)
2026-10-05 — AstraZeneca Completes $2 Billion Equity Investment in ... (businesswire.com)
2026-09-28 — AstraZeneca Makes $2 Billion Strategic Equity Investment ... (smmttx.com)
2026-08-06 — AstraZeneca, CSPC form joint biologics venture in China | Pharma Manufacturing (pharmamanufacturing.com)
2026-01-29 — AstraZeneca plans to invest $15 billion in China through 2030 to pioneer the next-generation of innovative medicines (astrazeneca.com)
2025-11-21 — AstraZeneca plans $2 billion manufacturing investment in Maryland, supporting 2,600 jobs and catalysing economic growth (astrazeneca.com)
Facilities
Astra Zeneca is headquartered in Cambridge, England. Public sources also reference these locations:
Virginia — astrazeneca.com
Shijiazhuang, China — pharmamanufacturing.com
Company details
The company serves more than 100 million patients annually and operates manufacturing and research facilities in Virginia and Shijiazhuang, China. Astra Zeneca was founded in 1999, has an estimated 50,000-100,000 employees, and is headquartered in Cambridge, England. On the LightSource stability read it is rated "Established & active": 27 years in operation (founded 1999). 10 US import shipments on record. Holds ISO 14001, ISO 50001 certification(s) per public sources.
Frequently asked questions
What does Astra Zeneca do?
AstraZeneca is a global biopharmaceutical company headquartered in Cambridge, England, founded in 1999 through a merger of Astra AB and Zeneca Group PLC. With approximately 90,000 employees and over $10 billion in annual revenue, it operates in more than 130 countries and serves oncology, cardiovascular, respiratory, immunology, vaccines, and rare disease sectors. The company announced a $15 billion investment plan in China through 2030 to develop next-generation medicines.
Where is Astra Zeneca headquartered?
Astra Zeneca is headquartered in Cambridge, England.
When was Astra Zeneca founded?
Astra Zeneca was founded in 1999.
How big is Astra Zeneca?
Astra Zeneca has an estimated 50,000-100,000 employees, with revenue in the $10B+ range (estimated).
What certifications does Astra Zeneca hold?
Astra Zeneca lists ISO 14001 · ISO 50001 on its website. Confirm the certified scope for the specific plant producing your part.
Does Astra Zeneca import from overseas suppliers?
US customs bill-of-lading records show 10 inbound shipments for Astra Zeneca, with top origins including Mexico.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
